Indications and uses
controls symptoms of diarrhea, including Travelers’ Diarrhea
controls symptoms of diarrhea, including Travelers’ Diarrhea
• drink plenty of clear fluids to help prevent dehydration caused by diarrhea • find right dose on chart. If possible, use weight to dose; otherwise, use age. adults and children 12 years and over 2 caplets after the first loose stool; 1 caplet after each subsequent loose stool; but no more than 4 caplets in 24 hours children 9-11 years (60-95 lbs) 1 caplet after the first loose stool; 1/2 caplet after each subseq...
• store at 20 ° -25 ° C (68 ° -77 ° F) • see end panel for lot number and expiration date
Loperamide HCl 2 mg
Anti-diarrheal
controls symptoms of diarrhea, including Travelers’ Diarrhea
Allergy alert: Do not use if you have ever had a rash or other allergic reaction to loperamide HCl
Heart alert: Taking more than directed can cause serious heart problems or death
if you have bloody or black stool
taking a prescription drug. Loperamide may interact with certain prescription drugs.
tiredness, drowsiness or dizziness may occur. Be careful when driving or operating machinery.
ask a health professional before use.
In case of overdose, get medical help or contact a Poison Control Center right away (1-800-222-1222).
adults and children 12 years and over | 2 caplets after the first loose stool; 1 caplet after each subsequent loose stool; but no more than 4 caplets in 24 hours |
children 9-11 years (60-95 lbs) | 1 caplet after the first loose stool; 1/2 caplet after each subsequent loose stool; but no more than 3 caplets in 24 hours |
children 6-8 years (48-59 lbs) | 1 caplet after the first loose stool; 1/2 caplet after each subsequent loose stool; but no more than 2 caplets in 24 hours |
children 2-5 years (34 to 47 lbs) | ask a doctor |
children under 2 years (up to 33 lbs) | do not use |
anhydrous lactose, carnauba wax, D&C yellow no. 10 aluminum lake, FD&C blue no. 1 aluminum lake, hypromellose, magnesium stearate, microcrystalline cellulose, polyethylene glycol, pregelatinized starch
1-800-719-9260
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 10f838ef-a72b-645d-80f8-e2255205c3b1 | Product name | 6 | 20240805 |
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 59779-700-53 | EA - Each | 59779-700 | 2041046b-da1d-43f0-9c54-920fa153f18b | 1 | 2021-06-02 |
| 59779-700-82 | EA - Each | 59779-700 | 3ef5af07-4cfd-472c-9c26-7d6c3247ca2e | 1 | 2021-05-05 |
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| LOPERAMIDE HYDROCHLORIDE | ACTIVE INGREDIENT | 77TI35393C | 3 | |
| LOPERAMIDE | ACTIVE MOIETY | 6X9OC3H4II | 3 | |
| ANHYDROUS LACTOSE | INACTIVE INGREDIENT | 3SY5LH9PMK | 3 | |
| CARNAUBA WAX | INACTIVE INGREDIENT | R12CBM0EIZ | 3 | |
| CELLULOSE, MICROCRYSTALLINE | INACTIVE INGREDIENT | OP1R32D61U | 3 | |
| HYPROMELLOSES | INACTIVE INGREDIENT | 3NXW29V3WO | 3 | |
| MAGNESIUM STEARATE | INACTIVE INGREDIENT | 70097M6I30 | 3 | |
| POLYETHYLENE GLYCOLS | INACTIVE INGREDIENT | 3WJQ0SDW1A | 3 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 59779-700 | 59779-700-53, 59779-700-89, 59779-700-68, 59779-700-67, 59779-700-72, 59779-700-08, 59779-700-80, 59779-700-82, 59779-700-91, 59779-700-62 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| LOPERAMIDE HYDROCHLORIDE | 77TI35393C | ACTIB |
| ANHYDROUS LACTOSE | 3SY5LH9PMK | IACT |
| CARNAUBA WAX | R12CBM0EIZ | IACT |
| HYPROMELLOSE, UNSPECIFIED | 3NXW29V3WO | IACT |
| MAGNESIUM STEARATE | 70097M6I30 | IACT |
| MICROCRYSTALLINE CELLULOSE | OP1R32D61U | IACT |
| POLYETHYLENE GLYCOL, UNSPECIFIED | 3WJQ0SDW1A | IACT |
| D&C YELLOW NO. 10 | 35SW5USQ3G | IACT |
| FD&C BLUE NO. 1 | H3R47K3TBD | IACT |
| Version | Effective date | Source | Hydrated |
|---|---|---|---|
| 9 | 2023-10-13 | full-release | 2026-05-31 23:56:46 |
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| CELLULOSE, MICROCRYSTALLINE | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | TABLET, FILM COATED / ORAL | 992 mg | ||
| MAGNESIUM STEARATE | MAGNESIUM STEARATE | 70097M6I30 | TABLET, FILM COATED / ORAL | 96 mg | ||
| HYPROMELLOSES | HYPROMELLOSE | 3NXW29V3WO | TABLET, FILM COATED / ORAL | 582 mg | ||
| HYPROMELLOSES | HYPROMELLOSE | 3NXW29V3WO | TABLET, FILM COATED / ORAL | 582 mg | ||
| CARNAUBA WAX | CARNAUBA WAX | R12CBM0EIZ | TABLET, FILM COATED / ORAL | 1 mg | ||
| ANHYDROUS LACTOSE | ANHYDROUS LACTOSE | 3SY5LH9PMK | TABLET, FILM COATED / ORAL | 2906 mg | ||
| MAGNESIUM STEARATE | MAGNESIUM STEARATE | 70097M6I30 | TABLET, FILM COATED / ORAL | 96 mg | ||
| CARNAUBA WAX | CARNAUBA WAX | R12CBM0EIZ | TABLET, FILM COATED / ORAL | 1 mg | ||
| HYPROMELLOSES | HYPROMELLOSE | 3NXW29V3WO | TABLET, FILM COATED / ORAL | 582 mg | ||
| CARNAUBA WAX | CARNAUBA WAX | R12CBM0EIZ | TABLET, FILM COATED / ORAL | 1 mg | ||
| CELLULOSE, MICROCRYSTALLINE | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | TABLET, FILM COATED / ORAL | 992 mg | ||
| CARNAUBA WAX | CARNAUBA WAX | R12CBM0EIZ | TABLET, FILM COATED / ORAL | 1 mg | ||
| MAGNESIUM STEARATE | MAGNESIUM STEARATE | 70097M6I30 | TABLET, FILM COATED / ORAL | 96 mg | ||
| MAGNESIUM STEARATE | MAGNESIUM STEARATE | 70097M6I30 | TABLET, FILM COATED / ORAL | 96 mg | ||
| ANHYDROUS LACTOSE | ANHYDROUS LACTOSE | 3SY5LH9PMK | TABLET, FILM COATED / ORAL | 2906 mg | ||
| ANHYDROUS LACTOSE | ANHYDROUS LACTOSE | 3SY5LH9PMK | TABLET, FILM COATED / ORAL | 2906 mg | ||
| CARNAUBA WAX | CARNAUBA WAX | R12CBM0EIZ | TABLET, FILM COATED / ORAL | 1 mg | ||
| MAGNESIUM STEARATE | MAGNESIUM STEARATE | 70097M6I30 | TABLET, FILM COATED / ORAL | 96 mg | ||
| CELLULOSE, MICROCRYSTALLINE | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | TABLET, FILM COATED / ORAL | 992 mg | ||
| ANHYDROUS LACTOSE | ANHYDROUS LACTOSE | 3SY5LH9PMK | TABLET, FILM COATED / ORAL | 2906 mg | ||
| HYPROMELLOSES | HYPROMELLOSE | 3NXW29V3WO | TABLET, FILM COATED / ORAL | 582 mg | ||
| CELLULOSE, MICROCRYSTALLINE | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | TABLET, FILM COATED / ORAL | 992 mg | ||
| CELLULOSE, MICROCRYSTALLINE | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | TABLET, FILM COATED / ORAL | 992 mg | ||
| MAGNESIUM STEARATE | MAGNESIUM STEARATE | 70097M6I30 | TABLET, FILM COATED / ORAL | 96 mg | ||
| HYPROMELLOSES | HYPROMELLOSE | 3NXW29V3WO | TABLET, FILM COATED / ORAL | 582 mg | ||
| MAGNESIUM STEARATE | MAGNESIUM STEARATE | 70097M6I30 | TABLET, FILM COATED / ORAL | 96 mg | ||
| MAGNESIUM STEARATE | MAGNESIUM STEARATE | 70097M6I30 | TABLET, FILM COATED / ORAL | 96 mg | ||
| ANHYDROUS LACTOSE | ANHYDROUS LACTOSE | 3SY5LH9PMK | TABLET, FILM COATED / ORAL | 2906 mg | ||
| CARNAUBA WAX | CARNAUBA WAX | R12CBM0EIZ | TABLET, FILM COATED / ORAL | 1 mg | ||
| CELLULOSE, MICROCRYSTALLINE | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | TABLET, FILM COATED / ORAL | 992 mg | ||
| HYPROMELLOSES | HYPROMELLOSE | 3NXW29V3WO | TABLET, FILM COATED / ORAL | 582 mg | ||
| CARNAUBA WAX | CARNAUBA WAX | R12CBM0EIZ | TABLET, FILM COATED / ORAL | 1 mg | ||
| HYPROMELLOSES | HYPROMELLOSE | 3NXW29V3WO | TABLET, FILM COATED / ORAL | 582 mg | ||
| CARNAUBA WAX | CARNAUBA WAX | R12CBM0EIZ | TABLET, FILM COATED / ORAL | 1 mg | ||
| ANHYDROUS LACTOSE | ANHYDROUS LACTOSE | 3SY5LH9PMK | TABLET, FILM COATED / ORAL | 2906 mg | ||
| CELLULOSE, MICROCRYSTALLINE | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | TABLET, FILM COATED / ORAL | 992 mg | ||
| MAGNESIUM STEARATE | MAGNESIUM STEARATE | 70097M6I30 | TABLET, FILM COATED / ORAL | 96 mg | ||
| MAGNESIUM STEARATE | MAGNESIUM STEARATE | 70097M6I30 | TABLET, FILM COATED / ORAL | 96 mg | ||
| CELLULOSE, MICROCRYSTALLINE | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | TABLET, FILM COATED / ORAL | 992 mg | ||
| HYPROMELLOSES | HYPROMELLOSE | 3NXW29V3WO | TABLET, FILM COATED / ORAL | 582 mg | ||
| MAGNESIUM STEARATE | MAGNESIUM STEARATE | 70097M6I30 | TABLET, FILM COATED / ORAL | 96 mg | ||
| ANHYDROUS LACTOSE | ANHYDROUS LACTOSE | 3SY5LH9PMK | TABLET, FILM COATED / ORAL | 2906 mg | ||
| HYPROMELLOSES | HYPROMELLOSE | 3NXW29V3WO | TABLET, FILM COATED / ORAL | 582 mg | ||
| ANHYDROUS LACTOSE | ANHYDROUS LACTOSE | 3SY5LH9PMK | TABLET, FILM COATED / ORAL | 2906 mg | ||
| CARNAUBA WAX | CARNAUBA WAX | R12CBM0EIZ | TABLET, FILM COATED / ORAL | 1 mg | ||
| ANHYDROUS LACTOSE | ANHYDROUS LACTOSE | 3SY5LH9PMK | TABLET, FILM COATED / ORAL | 2906 mg | ||
| CARNAUBA WAX | CARNAUBA WAX | R12CBM0EIZ | TABLET, FILM COATED / ORAL | 1 mg | ||
| CARNAUBA WAX | CARNAUBA WAX | R12CBM0EIZ | TABLET, FILM COATED / ORAL | 1 mg | ||
| CELLULOSE, MICROCRYSTALLINE | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | TABLET, FILM COATED / ORAL | 992 mg | ||
| ANHYDROUS LACTOSE | ANHYDROUS LACTOSE | 3SY5LH9PMK | TABLET, FILM COATED / ORAL | 2906 mg | ||
| CELLULOSE, MICROCRYSTALLINE | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | TABLET, FILM COATED / ORAL | 992 mg | ||
| HYPROMELLOSES | HYPROMELLOSE | 3NXW29V3WO | TABLET, FILM COATED / ORAL | 582 mg | ||
| CELLULOSE, MICROCRYSTALLINE | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | TABLET, FILM COATED / ORAL | 992 mg | ||
| ANHYDROUS LACTOSE | ANHYDROUS LACTOSE | 3SY5LH9PMK | TABLET, FILM COATED / ORAL | 2906 mg | ||
| HYPROMELLOSES | HYPROMELLOSE | 3NXW29V3WO | TABLET, FILM COATED / ORAL | 582 mg |
All distinct exact application/product contexts derived from this label’s complete NDC list are paginated below.
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A075232-001 | LOPERAMIDE HYDROCHLORIDE | LOPERAMIDE HYDROCHLORIDE | 2MG | TABLET / ORAL | 2000-01-06 |
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-10-15 13:18:30 | 2026-09 | A075232-001 | LOPERAMIDE HYDROCHLORIDE | 2MG | TABLET / ORAL | 2000-01-06 | c2088c7a36db… | ||
| 2026-09-14 22:38:34 | 2026-08 | A075232-001 | LOPERAMIDE HYDROCHLORIDE | 2MG | TABLET / ORAL | 2000-01-06 | 84e616aacf4f… | ||
| 2026-08-18 06:07:40 | 2026-07 | A075232-001 | LOPERAMIDE HYDROCHLORIDE | 2MG | TABLET / ORAL | 2000-01-06 | caaa826d4ba7… | ||
| 2026-02-19 14:30 UTC | 2026-02 | A075232-001 | LOPERAMIDE HYDROCHLORIDE | 2MG | TABLET / ORAL | 2000-01-06 | 011fe1cb6892… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A075232-001 | LOPERAMIDE HYDROCHLORIDE | 2MG | TABLET / ORAL | 2000-01-06 | 31067a03dcf5… | ||
| 2025-08-23 18:47 UTC | 2025-08 | A075232-001 | LOPERAMIDE HYDROCHLORIDE | 2MG | TABLET / ORAL | 2000-01-06 | 6a471c1ec25d… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A075232-001 | LOPERAMIDE HYDROCHLORIDE | 2MG | TABLET / ORAL | 2000-01-06 | fd3edfee7708… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A075232-001 | LOPERAMIDE HYDROCHLORIDE | 2MG | TABLET / ORAL | 2000-01-06 | b8a1b40f171c… | ||
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A075232-001 | LOPERAMIDE HYDROCHLORIDE | 2MG | TABLET / ORAL | 2000-01-06 | 03ed91905a0d… | ||
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A075232-001 | LOPERAMIDE HYDROCHLORIDE | 2MG | TABLET / ORAL | 2000-01-06 | 2680178bc6a6… | ||
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A075232-001 | LOPERAMIDE HYDROCHLORIDE | 2MG | TABLET / ORAL | 2000-01-06 | 5bbf6a4d5a75… | ||
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A075232-001 | LOPERAMIDE HYDROCHLORIDE | 2MG | TABLET / ORAL | 2000-01-06 | d8e5a09893c0… | ||
| 2024-10-29 15:01 UTC | 2024-10 | A075232-001 | LOPERAMIDE HYDROCHLORIDE | 2MG | TABLET / ORAL | 2000-01-06 | d06236e962d9… | ||
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A075232-001 | LOPERAMIDE HYDROCHLORIDE | 2MG | TABLET / ORAL | 2000-01-06 | 79d66fd596c7… | ||
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A075232-001 | LOPERAMIDE HYDROCHLORIDE | 2MG | TABLET / ORAL | 2000-01-06 | 301d65b070ca… | ||
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A075232-001 | LOPERAMIDE HYDROCHLORIDE | 2MG | TABLET / ORAL | 2000-01-06 | 1e350fbaab3a… | ||
| 2024-05-31 18:47 UTC | 2024-05 | A075232-001 | LOPERAMIDE HYDROCHLORIDE | 2MG | TABLET / ORAL | 2000-01-06 | 8072bd15b7f6… | ||
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A075232-001 | LOPERAMIDE HYDROCHLORIDE | 2MG | TABLET / ORAL | 2000-01-06 | 5c6f7cd8ea54… | ||
| 2022-04-08 23:34 UTC | 2022-04 | A075232-001 | LOPERAMIDE HYDROCHLORIDE | 2MG | TABLET / ORAL | 2000-01-06 | 5d02ea3f76ae… | ||
| 2022-04-04 05:41 UTC | 2022-04 | A075232-001 | LOPERAMIDE HYDROCHLORIDE | 2MG | TABLET / ORAL | 2000-01-06 | 4b0b4de00fa7… | ||
| 2019-12-13 00:20 UTC | 2019-12 | A075232-001 | LOPERAMIDE HYDROCHLORIDE | 2MG | TABLET / ORAL | 2000-01-06 | 74a2ff9319b5… | ||
| 2022-03-09 01:35 UTC | 2022-03 | A075232-001 | LOPERAMIDE HYDROCHLORIDE | 2MG | TABLET / ORAL | 2000-01-06 | bb7c543d1eb4… | ||
| 2021-12-28 21:50 UTC | 2021-12 | A075232-001 | LOPERAMIDE HYDROCHLORIDE | 2MG | TABLET / ORAL | 2000-01-06 | 782e0a99824c… | ||
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | A075232-001 | LOPERAMIDE HYDROCHLORIDE | 2MG | TABLET / ORAL | 2000-01-06 | 87673890dc5c… | ||
| 2021-03-12 10:30 UTC | 2021-03 | A075232-001 | LOPERAMIDE HYDROCHLORIDE | 2MG | TABLET / ORAL | 2000-01-06 | 5aa47cf7b7d7… | ||
| 2020-12-22 03:56 UTC | 2020-12 | A075232-001 | LOPERAMIDE HYDROCHLORIDE | 2MG | TABLET / ORAL | 2000-01-06 | 8869cabd3fbd… | ||
| 2020-11-12 02:37 UTC | 2020-11 | A075232-001 | LOPERAMIDE HYDROCHLORIDE | 2MG | TABLET / ORAL | 2000-01-06 | c0c555d07b60… | ||
| 2019-12-14 00:12 UTC | 2019-12 | A075232-001 | LOPERAMIDE HYDROCHLORIDE | 2MG | TABLET / ORAL | 2000-01-06 | 3f01610625f2… | ||
| 2019-09-15 20:21 UTC | 2019-09 | A075232-001 | LOPERAMIDE HYDROCHLORIDE | 2MG | TABLET / ORAL | 2000-01-06 | b00525d2431f… | ||
| 2019-07-19 19:46 UTC | 2019-07 | A075232-001 | LOPERAMIDE HYDROCHLORIDE | 2MG | TABLET / ORAL | 2000-01-06 | ea99ee380514… | ||
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | A075232-001 | LOPERAMIDE HYDROCHLORIDE | 2MG | TABLET / ORAL | 2000-01-06 | 6a51e52b5d6a… | ||
| 2024-02-18 07:12 UTC | 2024-02 | A075232-001 | LOPERAMIDE HYDROCHLORIDE | 2MG | TABLET / ORAL | 2000-01-06 | 1c564ffb4f44… | ||
| 2023-12-20 04:57 UTC | 2023-12 | A075232-001 | LOPERAMIDE HYDROCHLORIDE | 2MG | TABLET / ORAL | 2000-01-06 | ea1830bbd6c7… | ||
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | A075232-001 | LOPERAMIDE HYDROCHLORIDE | 2MG | TABLET / ORAL | 2000-01-06 | a72a2bbeb626… | ||
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | A075232-001 | LOPERAMIDE HYDROCHLORIDE | 2MG | TABLET / ORAL | 2000-01-06 | 9b2671bbb829… | ||
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | A075232-001 | LOPERAMIDE HYDROCHLORIDE | 2MG | TABLET / ORAL | 2000-01-06 | a67488948f0b… | ||
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | A075232-001 | LOPERAMIDE HYDROCHLORIDE | 2MG | TABLET / ORAL | 2000-01-06 | 3f0d92c62455… | ||
| 2023-05-13 08:27 UTC | 2023-05 | A075232-001 | LOPERAMIDE HYDROCHLORIDE | 2MG | TABLET / ORAL | 2000-01-06 | 053a50430f4f… | ||
| 2023-01-26 05:58 UTC | 2023-01 | A075232-001 | LOPERAMIDE HYDROCHLORIDE | 2MG | TABLET / ORAL | 2000-01-06 | 3bdfa0b2c4d7… | ||
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | A075232-001 | LOPERAMIDE HYDROCHLORIDE | 2MG | TABLET / ORAL | 2000-01-06 | 3a93d1ddd44b… |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| anti diarrheal | LOPERAMIDE HYDROCHLORIDE | CVS Pharmacy | d8a55fb6-bb57-42d6-8e20-67fc91f38097 | 2026-09-04 | Warnings | 59779-700-80 59779-700-68 59779-700-62 59779-700-89 59779-700-08 59779-700-53 59779-700-67 59779-700-91 59779-700-82 59779-700-72 59779-700 59779070089 59779070062 59779070072 59779070091 59779070082 59779070068 59779070080 59779070008 59779070067 59779070053 b0f6bd4a-62c2-4153-b911-47cd7f7cf9d1 d8a55fb6-bb57-42d6-8e20-67fc91f38097 |
Adverse event summaries are temporarily unavailable. Other product information remains available.